Reactivating p53 mutants selectively in patients.

Saved in:
Bibliographic Details
Title: Reactivating p53 mutants selectively in patients.
Authors: Chen S; Shanghai Immune Therapy Institute, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China., Shepard HM; Frontiers in Therapeutics Research Center, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Lu M; Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: min.lu@shsmu.edu.cn.
Source: Cancer cell [Cancer Cell] 2026 Apr 13; Vol. 44 (4), pp. 715-717. Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-3686
DOI:10.1016/j.ccell.2026.03.009